RxDoctor Payments DataLook up a doctor →

Michael Liebowitz

Psychiatry · New York, NYNPI 1265578629

Payments from drug & device makers

$7,068,984in general payments, 2019–2025

Across 478 payments — averaging $14,789 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$2.6M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2.4M
  • AbbVie$934K
  • Acadia Pharmaceuticals Inc$546K
  • Supernus Pharmaceuticals, Inc.$445K
  • Sunovion Pharmaceuticals Inc.$130K
  • plus $22K from 12 others
$119,344in research payments, 2019–2025

Across 31 payments — averaging $3849.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vanda Pharmaceuticals Inc.$116K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
  • Acadia Pharmaceuticals Inc$1K
  • AbbVie$3

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,068,984 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Other psychiatry in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →